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Vulva
Local examination of vulva revealed a large (8 by 10 cm) irregular
lesion, present over the left labia majora and mons pubis (Fig. 1). The
lesion had appearance of multiple conﬂuent nodular lesions each
measuring about 0.5 to 2 cm. On palpation the lesion was ﬁrm to
hard, indurated and non-tender with clear margins. The lesion was
noticed to cross the midline involving clitoris. There were no palpable
inguinal or supraclavicular nodes.
Ultrasonography revealed a lobular solid tumor in the subcutaneous
plane. Tumor markers (CA-125, carcinoembryonic antigen, desmin and
epithelialmembrane antigen)were negative. Sheunderwentwide exci-
sion, ensuring clear margins using frozen section procedure. This wasIntroduction
Solitary ﬁbrous tumor (SFT) is a rare mesenchymal neoplasm and
accounts for less than 2% of all soft tissue tumors. Moreover, the genital
tract location of this tumor is even rarer, with just 5 cases of vulval SFT
reported in literature (Taki et al., 2012). We recently managed a case of
SFT of vulva which was diagnosed initially as dermatoﬁbrosarcoma
protuberans. In this article we intend to discuss this case and review
the limited available literature for various presentations, diagnosis and
treatment outcomes of vulval SFT.Presentation of case
A 57 year old female presented with complaints of painless swelling
over the vulva which has been slowly increasing in size over the past
10 years. There was no history of fever, weight loss, loss of appetite, dis-
charge, or pigmentation. A biopsy performed elsewhere previously, had
diagnosed the current lesion as ‘dermatoﬁbrosarcoma protuberans’
(DFS). Past historywas signiﬁcant for similar lesion at the same location
whichwas excised about twenty years ago. There was no past history of
tuberculosis including her family.SA 5043, Australia.
. This is an open access article underfollowed by skin grafting from the thigh (Fig. 1). Histopathology of the
excised lesion was reported as SFT. The tumor was smooth and white
on cross-section. The microscopic picture was that of a pattern less
ﬁbroblastic spindle cells in a hyalinized collagen matrix (Fig. 2). On
immunohistochemical staining, the tumor was positive for CD34 and
bcl-2, but negative for S-100, a SMA, EMA and AE1/AE3. No adjuvant
therapy was administered and the patient made an un-eventful recov-
ery, with no recurrence so far for 24 months.Discussion
The case discussed is that of an unusual presentation of a rare neo-
plasm of soft tissue — the SFT. This tumor was ﬁrst described arising
from the pleura in 1931 (Hasegawa et al., 1999), which is the most
common site. Since then, it has been described at locations such as the
meninges, peritoneum, liver, upper respiratory tract, orbit, thyroid,
and salivary gland (Hasegawa et al., 1999). Gynecological SFT, how-
ever, is a rare entity (Taki et al., 2012). Of all the reports on gyneco-
logical SFTs, the vulval origin has been described in only ﬁve reports
(Table 1) (Taki et al., 2012; Fukunaga, 2000; Nielsen et al., 1997;
Biedrzycki et al., 2007; He et al., 2010).
The age of our patient at presentationwas similar to the age reported
in literature for gynecological SFT, which is an average of 50 years,
ranging from 14 years to 78 years. The presentation is that of a slowly
growing painless lump. The tumor in this case grew over 10 years to a
signiﬁcant size of 8 × 10 cm. This slow growth along with the absence
of nuclear atypia and metastasis suggests benign nature.
Histologically, it is characterized by ﬁbroblastic spindle cell prolifer-
ation arranged in no particular pattern in a collagenous stroma. The im-
portant differentials for this tumor are the spindle cell tumors, tumors of
neural origin, smoothmuscle tumors, hemangiopericytoma (HPC), DFS,the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. (A) Vulval solitary ﬁbrous tumor 8 × 10 cm involving clitoris, (B) Wide excision and skin grafting.
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discussed, the tumor was reported initially to be a DFS; however it
was found later to be a SFT. Both SFT and DFS express CD34 reactivity.
However, hyalinization was noticed in the present tumor and this is
not a feature of DFS; moreover, features of prominent storiform pattern
and xanthomatous cells seen inDFSwere absent. Immunohistochemical
detection of CD34 and bcl-2 was helpful in differentiating SFT from
other spindle-cell tumors (Hasegawa et al., 1998). Immunostaining for
S-100 can exclude tumors of neural origin. Smooth muscle tumors
show lesional reactivity for smooth muscle actin, while SFT only
shows reactivity in vessel walls. This reactivity pattern of SFT is not
seen in HPC, and hence helps in differentiation. Spindle cell lipoma
can be differentiated by the presence of mature fat cells whichwere ab-
sent in this case. In SFT, certain pathological features predict aggressive
and malignant behavior and hence are important to look for, as these
have prognostic and treatment implications. None of these features
were seen in our case or in any of the reported cases of vulval SFT
(Taki et al., 2012; Fukunaga, 2000; Nielsen et al., 1997; Biedrzycki
et al., 2007; He et al., 2010). These pathological features include — nu-
clear atypia, hypercellularity, frequent mitoses, necrosis and inﬁltrative
growth. Besides these, immunohistochemical staining positivity with
α-SMA and S-100 has been shown to predict malignant behavior
(Vallat-Decouvelaere et al., 1998). Adjuvant radiotherapy is often per-
formed following excision in these cases.
The tumor involves the adjacent tissues requiring signiﬁcant exci-
sion, has recurrences and there is at least one case report of metastasis
(Vallat-Decouvelaere et al., 1998). Hence, despite benign behavior,
early aggressive management with wide excision ensuring clear mar-
gins is recommended.Wide excisions do have signiﬁcant functional im-
pairment and hence a precise pathological studies and imaging areFig. 2. (A) Hematoxylin and eosin stained section (×100) showing patternless arrangemenecessary. Due to its superﬁcial location ultrasound was done to assess
the nature and extent of the mass. There are case reports of excessive
bleeding associated with resection and hence particularly in deeper
SFTs, contrast enhanced imaging to assess the vascularity has been rec-
ommended. Due to recurrent nature, a long term follow-upmust be ad-
vised. Unfortunately, for vulval SFT, there is nodata on long term follow-
up. Our case report has longest reported follow-up period for vulval SFT.
Similar to our case, there has been no reported recurrence of vulval SFT
prospectively, so far. Recurrence, however, is a known phenomenon for
gynecological SFTs in other locations (Vallat-Decouvelaere et al., 1998).
Our case had a history of similar presentation; hence the current lesion
may be a recurrence. However, in the absence of histopathological evi-
dence, this is difﬁcult to substantiate.
Conclusion
In conclusion, the clinicians and pathologists should be aware of this
rare differential of vulval mass. Although usually benign, the tumor re-
quires thorough pathological and radiological workup to rule outmalig-
nant features and other close differentials. Early aggressive resection is
recommended due to destructive nature of this tumor on adjacent tis-
sues. The tumor has a tendency for recurrence and hence the resected
margins should be clear and long term follow-up should be arranged.
Although the experience with follow-up of this tumor is scarce, the
prognosis depends on complete surgical resection and lack of patholog-
ical features of malignancy.
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Table 1
Case reports of vulval solitary ﬁbrous tumor.
Author Age (Years) Size and presentation Immuno-histochemical staining Outcomea
Taki et al. (2012) 56 5 cm; no symptoms CD34+ve, and AE1/AE3, EMA, S-100, a-SMA−ve. No recurrence for at
least 18 months
Fukunaga (2000) 70 15 cm; 15 years of slow growing mass Vimentin, CD34, progesterone receptors, and bcl-2+ve. No recurrence for at
least 9 months
Nielsen et al. (1997) 51 5 cm; painless slowly growing lump Vimentin, CD34+ve, and cytokeratin, desmin,
S-100 protein, EMA, SMA−ve.
No recurrence for at
least 12 months
Biedrzycki et al. (2007) 45 6 cm; painless slowly growing lump CD34, Bcl 2, and vimentin, CD99+ve. MNF116,
desmin, SMA, ER, PR, and S100−ve.
No recurrence for at
least 6 months
He et al. (2010) 39 10 cm; slowly growing painless lump CD99, vimentin, CD34+ve. S100, SMA, desmin, ER, PR−ve. No recurrence for at
least 10 months
a All cases involved wide excision.
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